Two weeks ago, I had the joy of sharing my recent trip to our son’s wedding, which was made possible by the generosity of others. During my trip to Houston, I met with a friend of mine who is also a counselor, Jennifer Christian. She interviewed…
Turning to Self-Compassion in Difficult Times
4 Things to Consider Before Getting a Service Dog
Having a service dog can greatly enhance the life of someone living with a chronic disease. They allow patients to regain some of their independence by helping with small everyday tasks like opening and closing doors, fetching meds, acting as a prop or support as their owner stands, switching on lights and attracting attention…
Treatment with Galecto Biotech’s inhaled TD139 may become an effective and safe option for patients with idiopathic pulmonary fibrosis (IPF), according to a clinical trial conducted by Scotland’s University of Edinburgh. Galecto, a Danish pharmaceutical firm, will present the study’s findings at the American Thoracic Society 2017 International Conference…
Understanding the Stages of Pulmonary Fibrosis
When a person is diagnosed with pulmonary fibrosis (PF), they may also go through additional tests so doctors can determine the stage of the disease. Staging of pulmonary fibrosis is important to establish the optimal treatment plan and to offer the patient an accurate prognosis. MORE: Eight of the most common lung diseases in women. The…
The Pulmonary Fibrosis Foundation’s (PFF) annual walk is happening in Lincoln Park, Chicago on September 9. While other major cities across the U.S. will be hosting walks, you can still participate even if you can’t make it to any of the listed locations. MORE: Woman with pulmonary fibrosis…
The resokine protein reduced interstitial lung disease (ILD) in mice, according to one of two presentations that aTyr Pharma will make at the American Thoracic Society International Conference in Washington, which starts today. Atry derived its Resolaris therapy from resokine, which helps prevent the immune system from turning against healthy cells. Scientists…
9 Tips to Lower Your Risk of Lung Disease
Lung disease is one of the main causes of American deaths, second only to heart disease. While some lung diseases are genetic and unavoidable, following a healthy lifestyle and avoiding lung irritants can help protect you from developing many of them. We’ve put together a list of tips to help lower your risk of developing a…
Genoa Pharmaceuticals has completed a $62 million Series A financing round to pursue a Phase 2 clinical trial of Aerodone (inhaled pirfenidone) to treat idiopathic pulmonary fibrosis (IPF). The Seattle-based company also appointed Dr. Ketan Patel, Dr. Naveed Siddiqi, Tiba Aynechi, Niall O’Donnell and Dr. Heather Preston to its board of directors. Dr. Jonathan Leff,…
Gentle exercise has many health benefits, particularly for anyone suffering from a chronic illness. In this video, personal trainer Ryan Krane demonstrates some simple exercises that can help counter the effects of chronic fatigue. MORE: While there’s currently no known cure for IPF, there are treatments available…
New York scientists have created a mini-lung in a laboratory that mimics a real lung’s response to a viral infection in pulmonary fibrosis. The mini-lung, which scientists call an organoid, will increase understanding of lung diseases,  leading to better treatments, the researchers said. Dr. Hans-Willem Snoeck, a professor at Columbia University…
Your PF Community
Recent Posts
- IPF drug Esbriet lowers risk of irregular heartbeats by nearly 90%, per study February 11, 2026
- Every patient’s journey with IPF is part of a unique mystery February 10, 2026
- New IPF therapy modulates genes tied to inflammation and scarring February 4, 2026
- My journey with PF and transplant means lifelong medical surveillance February 3, 2026
- Learning about the link between autoimmune disease and PF January 29, 2026
